Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 2, 2006, Pages 364-370

  Akimoto, Tetsuo ^a   Katoh, Hiroyuki ^a   Kitamoto, Yoshizumi ^a   Tamaki, Tomoaki ^a   Harada, Kosaku ^a   Shirai, Katsuyuki ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

High dose rate brachytherapy; Hypofractionation; Prostate cancer; Rectal bleeding

Indexed keywords

DOSIMETRY; FRACTIONATION; RADIOTHERAPY; RESPIRATORY THERAPY;

HIGH-DOSE-RATE BRACHYTHERAPY; HYPOFRACTIONATION; PROSTATE CANCER; RECTAL BLEEDING;

TUMORS;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CORRELATION ANALYSIS; DOSIMETRY; EVALUATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM HEMORRHAGE; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; DOSE FRACTIONATION; GASTROINTESTINAL HEMORRHAGE; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTAL DISEASES; RECTUM;

EID: 33646250661     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.12.017     Document Type: Article

References (19)

1. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46 (2000) 391-402
2. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment. Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41 (1998) 501-510
3. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer. Report of a dose escalation study. Int J Radiat Oncol Biol Phys 37 (1997) 543-550
4. Fowler J., Chappell R., and Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
5. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
6. Akimoto T., Kitamoto Y., Niibe H., et al. External-beam radiation therapy for clinically node negative, localized hormone refractory prostate cancer. Impact of the pretreatment PSA value on radiotherapeutic outcomes. Int J Radiat Oncol Biol Phys 59 (2004) 372-379
7. Akimoto T., Muramatsu H., Nakano T., et al. Rectal bleeding after hypofractionated radiotherapy for prostate cancer. Correlation between clinical and dosimetric parameters and the incidence of Grade 2 or higher rectal bleeding. Int J Radiat Oncol Biol Phys 60 (2004) 1033-1039
8. Akimoto T., Ito K., Niibe H., et al. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer. Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63 (2005) 463-471
9. Akimoto T., Katoh H., Noda S.E., et al. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer. Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 63 (2005) 472-478
10. Nag S., and Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 46 (2000) 507-513
11. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
12. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
13. Polack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response. Results of the M.D. Anderson Phase III randomized study. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1150
14. Chism D.B., Horwitz E.M., Hanlon A.L., et al. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys 55 (2003) 71-77
15. Hsu I.C., Pickett B., Shinohara K., et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external-beam radiotherapy boost. Potential for dose escalation. Int J Radiat Oncol Biol Phys 46 (2000) 851-858
16. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
17. Huang E., Dong L., Chandra A., et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 261-268
18. Kestin L.L., Martinez A.A., Stromberg J.S., et al. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 18 (2000) 2869-2880
19. Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcomes in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 316-327